Immediate Impact
1 from Science/Nature 38 standout
Citing Papers
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
2025 Standout
Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy
2025 Standout
Works of Carlos Linn being referenced
Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial
2021 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Carlos Linn | 85 | 192 | 26 | 94 | 91 | 14 | 268 | |
| Soizick Mesnage | 41 | 164 | 35 | 122 | 99 | 9 | 254 | |
| Alisia Cesta | 58 | 189 | 52 | 98 | 60 | 20 | 330 | |
| Shyam Aggarwal | 53 | 142 | 32 | 72 | 52 | 19 | 262 | |
| Luisa Sánchez‐Lorenzo | 37 | 184 | 20 | 57 | 43 | 17 | 269 | |
| Ahmed Kamel | 46 | 108 | 24 | 122 | 46 | 13 | 276 | |
| Mei Cao | 69 | 153 | 27 | 37 | 117 | 15 | 305 | |
| Lorenzo Alonso-Carrión | 27 | 96 | 32 | 42 | 103 | 12 | 286 | |
| K.S. Grzankowski | 17 | 102 | 27 | 67 | 111 | 17 | 235 | |
| Maria Kfoury | 58 | 218 | 19 | 21 | 129 | 22 | 281 | |
| Lily Xu | 28 | 169 | 33 | 30 | 162 | 12 | 322 |
All Works
Login with ORCID to disown or claim papers
Loading papers...